Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.6996
+0.0181 (2.66%)
At close: Oct 30, 2026, 4:00 PM EST
0.6703
-0.0293 (-4.19%)
Pre-market: Nov 2, 2026, 8:37 AM EST
Daré Bioscience Stock Forecast
DARE's stock price has decreased by -65.37% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Daré Bioscience stock has a consensus rating of "Strong Buy" and an average price target of $6.33. The average 1-year stock price forecast is 805.23% higher than the current stock price, while the lowest is $2.00 (+185.88%) and the highest is $12 (+1,615.27%).
Price Target: $6.33 (+805.23%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Daré Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $2 | Buy | Initiates | $2 | +185.88% | Oct 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +1,615.27% | Sep 22, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +1,043.51% | Aug 15, 2026 |
Financial Forecast
Revenue This Year
2.23M
from 1.03M
Increased by 116.54%
Revenue Next Year
6.72M
from 2.23M
Increased by 201.20%
EPS This Year
-0.79
from -1.20
EPS Next Year
-0.51
from -0.79
EPS and Forward PE are based on non-GAAP adjusted numbers.